The National Institutes of Health is offering this grant to support the development of innovative, long-acting Multipurpose Prevention Technologies (MPTs). This grant is for the purpose of creating new systemic and non-systemic methods that simultaneously prevent HIV infection and pregnancy in adolescent and young women. Research may include pharmacokinetic, pharmacodynamic, safety, and drug-drug interaction studies. It also encourages biobehavioral and behavioral/social studies to identify end-user preferences regarding MPT characteristics like appearance, feel, effectiveness, safety, and duration. This initiative aims to understand and promote factors that will increase MPT adoption and use among this target population.
Opportunity ID: 335498
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-298 |
| Funding Opportunity Title: | Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 31, 2021 |
| Last Updated Date: | Aug 31, 2021 |
| Original Closing Date for Applications: | Dec 09, 2023 |
| Current Closing Date for Applications: | Dec 09, 2023 |
| Archive Date: | Jan 14, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies. It also encourages biobehavioral and behavioral/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-298.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 335498 Full Announcement-PAR-21-298 -> PAR-21-298-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270938 | Dec 16, 2021 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268755 | Nov 09, 2021 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278360 | Nov 14, 2022 | Dec 09, 2023 | View |
Package 1
Mandatory forms
335498 RR_SF424_5_0-5.0.pdf
335498 PHS398_CoverPageSupplement_5_0-5.0.pdf
335498 RR_OtherProjectInfo_1_4-1.4.pdf
335498 PerformanceSite_4_0-4.0.pdf
335498 RR_KeyPersonExpanded_4_0-4.0.pdf
335498 RR_Budget_3_0-3.0.pdf
335498 RR_SubawardBudget30_3_0-3.0.pdf
335498 PHS398_ResearchPlan_4_0-4.0.pdf
335498 SBIR_STTR_Information_3_0-3.0.pdf
335498 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335498 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335498 RR_SF424_2_0-2.0.pdf
335498 PHS398_CoverPageSupplement_5_0-5.0.pdf
335498 RR_OtherProjectInfo_1_4-1.4.pdf
335498 PerformanceSite_2_0-2.0.pdf
335498 RR_KeyPersonExpanded_2_0-2.0.pdf
335498 RR_Budget_1_4-1.4.pdf
335498 RR_SubawardBudget30_1_4-1.4.pdf
335498 PHS398_ResearchPlan_4_0-4.0.pdf
335498 SBIR_STTR_Information_1_3-1.3.pdf
335498 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335498 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
335498 RR_SF424_5_0-5.0.pdf
335498 PHS398_CoverPageSupplement_5_0-5.0.pdf
335498 RR_OtherProjectInfo_1_4-1.4.pdf
335498 PerformanceSite_4_0-4.0.pdf
335498 RR_KeyPersonExpanded_4_0-4.0.pdf
335498 RR_Budget_3_0-3.0.pdf
335498 RR_SubawardBudget30_3_0-3.0.pdf
335498 PHS398_ResearchPlan_5_0-5.0.pdf
335498 SBIR_STTR_Information_3_0-3.0.pdf
335498 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335498 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
